Biologic Drug Patents in Belgium
✉ Email this page to a colleague
Drug Patents in Belgium and US Equivalents
Patent Number | Publication Date | US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
---|---|---|---|---|---|---|
898016 | Feb 15, 1984 | ⤷ Try a Trial | 2003-05-13 | interferon beta-1b | Bayer Healthcare Pharmaceuticals Inc. | BETASERON |
898016 | Feb 15, 1984 | ⤷ Try a Trial | 2005-04-12 | interferon beta-1b | Bayer Healthcare Pharmaceuticals Inc. | BETASERON |
2010C021 | Dec 04, 2018 | ⤷ Try a Trial | 2018-09-25 | rilonacept | Kiniksa Pharmaceuticals (uk), Ltd. | ARCALYST |
2010C021 | Dec 04, 2018 | ⤷ Try a Trial | 2018-09-25 | rilonacept | Kiniksa Pharmaceuticals (uk), Ltd. | ARCALYST |
2013C029 | Mar 06, 2019 | ⤷ Try a Trial | 2019-06-08 | aflibercept | Regeneron Pharmaceuticals, Inc. | EYLEA |
>Patent Number | >Publication Date | >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |